GalNAc-siRNA

Advertisement

cGxPJobs Banner

Wave Life Sciences Initiates Phase 2a INLIGHT™ Trial of WVE-007 for Obesity and Cardiometabolic Diseases

CAMBRIDGE, Mass., June 24, 2026 Wave Life Sciences announced the initiation of the Phase 2a multidose portion of the...

By cGxPwire Editor
June 26, 2026

Read More

Tangram Advances TGM-312 With Phase 1/2 CTA Submission

LONDON — November 26, 2025. Tangram Therapeutics has submitted a Clinical Trial Application (CTA) to the UK Medicines and...

By cGxPwire Editor
November 26, 2025

Read More

Advertisement

cGxPJobs

Directory